Position in BIOA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$14,882,136
+$9,287,884 QoQ
Shares Held
850,894
+101.2% QoQ
Ownership
1.91%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 18.93103018707383.ToString("F0")%
Shared 0.ToString("F0")%
None 81.06896981292617.ToString("F0")%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $7,513,489,070 across 54 Drug Manufacturers - Specialty & Generic names. BIOA ranks #30 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
19,324,401 | $2,284,337,442 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
1,843,963 | $1,093,433,179 | |
| 3 | VTRS |
Viatris Inc
|
52,233,699 | $705,677,273 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
4,354,526 | $573,665,255 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
17,790,020 | $535,835,402 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
15,336,479 | $367,001,942 | |
| 7 | ALKS |
Alkermes plc.
|
9,465,286 | $334,692,512 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
2,429,803 | $184,300,557 |
All Filings in BIOA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,882,136 | 850,894 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,594,252 | 422,846 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,164,892 | 198,111 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $664,306 | 160,849 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $394,160 | 104,830 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $274,498 | 47,409 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||